{"product_id":"fda-anda-216937-approval-letter-for-nimodipine-oral-solution","title":"FDA ANDA 216937, Approval Letter for Nimodipine Oral Solution","description":"\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eContents:\u003c\/strong\u003e ANDA approval letter for ANDA 216937, Nimodipine Oral Solution, 3 mg\/ml held by Annora Pharma which was approved July 9, 2024.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eDrug Name\u003c\/strong\u003e: NIMODIPINE\u003cbr\u003e\u003cstrong\u003eActive Ingredients\u003c\/strong\u003e: NIMODIPINE\u003cbr\u003e\u003cstrong\u003eStrength\u003c\/strong\u003e: 3MG\/ML\u003cbr\u003e\u003cstrong\u003eDosage Form \/ Route\u003c\/strong\u003e: SOLUTION;ORAL\u003cbr\u003e\u003cstrong\u003eAction Date\u003c\/strong\u003e: 07\/09\/2024\u003cbr\u003e\u003cstrong\u003eMarketing Status\u003c\/strong\u003e: Prescription\u003c\/span\u003e\u003c\/p\u003e","brand":"FDA","offers":[{"title":"Default Title","offer_id":50682948583588,"sku":"FDAANDA216937","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/fda-anda-216937-approval-letter-for-nimodipine-oral-solution","provider":"FOIA Document Source","version":"1.0","type":"link"}